• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

15.90 -0.26 (-1.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
NeoGenomics Reports Second Quarter 2026 Results
July 28, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
July 20, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
July 09, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
July 07, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Appoints Carolyn Starrett to its Board of Directors
June 25, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
June 17, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
June 15, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
May 26, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
May 15, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Reports First Quarter 2026 Results
April 28, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
April 23, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
April 13, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
April 07, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
March 16, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
February 25, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
February 18, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
February 17, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
February 12, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
January 27, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
January 12, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
December 30, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
December 15, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present New ctDNA Research at SABCS 2025
December 10, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
December 08, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Participate in Upcoming Investor Conferences
November 06, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
October 30, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics Reports Third Quarter 2025 Results
October 28, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
October 14, 2025
From NeoGenomics, Inc.
Via Business Wire
News headline image
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
October 07, 2025
From NeoGenomics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap